Reportable Segments | Segment Information: Our three reportable segments include Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. This structure aligns with the markets and customers we serve through each of the segments. The structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions. Summarized financial information concerning our reportable segments is shown in the following tables. The “All Other” category comprises operating segments that did not fit into any of our core businesses. During the first quarter of 2016 , we completed the sales of the metal sulfides business and the minerals-based flame retardants and specialty chemicals businesses. For additional information about these businesses, see Note 3, “Divestitures.” Following the sales of these businesses, the “All Other” category includes only the fine chemistry services business. The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the operating segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs. The Company’s chief operating decision maker uses earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items such as acquisition and integration related costs, utilization of inventory markup, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items (“adjusted EBITDA”), in a balanced manner and on a segment basis to assess the ongoing performance of the Company’s business segments and to allocate resources. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP. Three Months Ended 2017 2016 (In thousands) Net sales: Lithium and Advanced Materials $ 284,375 $ 216,173 Bromine Specialties 219,191 196,553 Refining Solutions 185,412 170,579 All Other 32,419 72,089 Corporate 666 1,817 Total net sales $ 722,063 $ 657,211 Adjusted EBITDA: Lithium and Advanced Materials $ 120,022 $ 86,474 Bromine Specialties 68,488 61,608 Refining Solutions 49,579 55,074 All Other 5,156 8,464 Corporate (31,869 ) (19,587 ) Total adjusted EBITDA $ 211,376 $ 192,033 See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, from Net income (loss) attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands): Lithium and Advanced Materials Bromine Specialties Refining Solutions Reportable Segments Total All Other Corporate Consolidated Total Three months ended March 31, 2017 Net income (loss) attributable to Albemarle Corporation $ 94,106 $ 58,694 $ 40,474 $ 193,274 $ 3,246 $ (145,307 ) $ 51,213 Depreciation and amortization 22,743 9,794 9,105 41,642 1,910 1,518 45,070 Utilization of inventory markup (a) 10,606 — — 10,606 — — 10,606 Restructuring and other (b) — — — — — 12,905 12,905 Gain on acquisition (c) (7,433 ) — — (7,433 ) — — (7,433 ) Acquisition and integration related costs (d) — — — — — 14,281 14,281 Interest and financing expenses (e) — — — — — 68,513 68,513 Income tax expense — — — — — 11,971 11,971 Non-operating pension and OPEB items — — — — — (1,063 ) (1,063 ) Other (f) — — — — — 5,313 5,313 Adjusted EBITDA $ 120,022 $ 68,488 $ 49,579 $ 238,089 $ 5,156 $ (31,869 ) $ 211,376 Three months ended March 31, 2016 Net income (loss) attributable to Albemarle Corporation $ 63,327 $ 51,853 $ 46,314 $ 161,494 $ 130,709 $ (64,017 ) $ 228,186 Depreciation and amortization 23,147 9,755 8,760 41,662 612 1,335 43,609 (Gain) loss on sales of businesses, net (g) — — — — (122,857 ) 1,533 (121,324 ) Acquisition and integration related costs (d) — — — — — 18,558 18,558 Interest and financing expenses — — — — — 15,114 15,114 Income tax expense — — — — — 25,485 25,485 Income from discontinued operations (net of tax) — — — — — (17,312 ) (17,312 ) Non-operating pension and OPEB items — — — — — (283 ) (283 ) Adjusted EBITDA $ 86,474 $ 61,608 $ 55,074 $ 203,156 $ 8,464 $ (19,587 ) $ 192,033 (a) In connection with the acquisition of Jiangli New Materials, the Company valued inventory purchased from Jiangli New Materials at fair value, which resulted in a markup of the underlying net book value of the inventory totaling approximately $23.0 million . The inventory markup is being expensed over the estimated remaining selling period. For the three-month period ended March 31, 2017, $10.6 million was included in Cost of goods sold related to the utilization of the inventory markup. (b) During the first quarter of 2017, we initiated action to reduce costs at several locations, primarily at our Lithium site in Germany. Based on the restructuring plans, we have recorded expenses of $2.9 million in Cost of goods sold, $4.2 million in Selling, general and administrative expenses and $5.8 million in Research and development expenses, primarily related to severance, expected to be incurred. The unpaid balance is recorded in Accrued expenses at March 31, 2017, with the expectation that the majority of this plan will be completed by the end of 2017. (c) Gain recorded in Other (expenses) income, net related to the acquisition of the remaining 50% interest in Salmag. See Note 2, “Acquisitions,” for additional information. (d) See Note 2, “Acquisitions,” for additional information. (e) Included in Interest and financing expenses is a loss on early extinguishment of debt of $52.8 million . See Note 10, “Long-term Debt,” for additional information. (f) Included in Other (expenses) income, net are $3.2 million of asset retirement obligation charges related to the revision of an estimate at a site formerly owned by Albemarle and a loss of $2.1 million associated with the previous disposal of a business. (g) See Note 3, “Divestitures,” for additional information. |